EIF5A2 and cervical carcinoma: Higher EIF5A2 expression was correlated with aggressive characteristics of cervical cancer, and serves as a biomarker for shorter overall survival and disease-free survival in FIGO stage II patients and in patients with a negative pelvic lymph node status [80].